K Number
K051587
Date Cleared
2005-10-25

(132 days)

Product Code
Regulation Number
868.5800
Panel
AN
Reference & Predicate Devices
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

TRACOE Vario Tracheostomy Tubes are indicated for providing tracheal access for airway management in patients with unusual anatomy or thick neck patients.

Device Description

Not Found

AI/ML Overview

The provided document is a 510(k) premarket notification letter from the FDA regarding Tracoe-Vario Tracheostomy Tubes. It states that the device is substantially equivalent to a legally marketed predicate device (Bivona TTS Adjustable Neck Flange Tracheostomy Tube).

However, this document does not contain any information about:

  • Acceptance criteria for device performance.
  • A study proving the device meets acceptance criteria.
  • Sample sizes for test or training sets.
  • Data provenance.
  • Number of experts or their qualifications for ground truth establishment.
  • Adjudication methods.
  • Multi-reader multi-case (MRMC) studies or effect sizes.
  • Standalone algorithm performance.
  • Type of ground truth used.
  • How ground truth for training was established.

Therefore, I cannot fulfill your request using the provided input. The document is solely an FDA clearance letter based on substantial equivalence, not a detailed study report.

§ 868.5800 Tracheostomy tube and tube cuff.

(a)
Identification. A tracheostomy tube and tube cuff is a device intended to be placed into a surgical opening of the trachea to facilitate ventilation to the lungs. The cuff may be a separate or integral part of the tracheostomy tube and is, when inflated, intended to establish a seal between the tracheal wall and the tracheostomy tube. The cuff is used to prevent the patient's aspiration of substances, such as blood or vomit, or to provide a means for positive-pressure ventilation of the patient. This device is made of either stainless steel or plastic.(b)
Classification. Class II.